Medical Research

ADHD and Early Death: What a 15.9-Million-Person Study Found, and Why Treatment Matters
|

ADHD and Early Death: What a 15.9-Million-Person Study Found, and Why Treatment Matters

Most people think of ADHD as a focus problem. A kid who can’t sit still in class. An adult who loses their keys three times a week. Annoying, sure, but not dangerous. A large new review says we need to take it more seriously than that. Researchers in the UK pooled data from 19 studies…

Gene Therapy Helped Adult Retinas Repair Damaged Wiring in New Study
|

Gene Therapy Helped Adult Retinas Repair Damaged Wiring in New Study

For a long time, the accepted view was that the retina’s nerve wiring is set in childhood and that adult nerve cells can be protected but not rebuilt. A new study from Michigan State University challenges that view. With a single dose of gene therapy, researchers restored vision in adult dogs born with an inherited…

New Experimental Drug Targets Dangerous Belly Fat by Killing Fat Cells
|

New Experimental Drug Targets Dangerous Belly Fat by Killing Fat Cells

Here’s something most of my patients don’t know: when you lose weight, your fat cells don’t go away. They just get smaller, and they’re ready to fill back up the moment your habits slip. That’s a big reason so many people regain weight after a diet or after stopping a GLP-1 medication. Now researchers are…

New Injection Targets Belly Fat by Destroying Fat Cells, Early Trials Show
|

New Injection Targets Belly Fat by Destroying Fat Cells, Early Trials Show

GLP-1 drugs like Ozempic and Wegovy help many people lose weight, but keeping it off after stopping the medication is hard. An experimental injection called CBL-514 takes a different approach. Instead of shrinking fat cells, it makes them die off on their own. In early human trials, it reduced both the fat under the skin…

40Hz Light and Sound Therapy for Alzheimer’s: What the Science Shows So Far
|

40Hz Light and Sound Therapy for Alzheimer’s: What the Science Shows So Far

Picture an Alzheimer’s treatment with no pills, no infusions, and no surgery, just an hour a day of light flickering and sound pulsing 40 times per second. It sounds too simple to work, yet it has reached phase III clinical testing. The need is real. Newer drugs clear amyloid plaques but slow decline by only…

Yale Researchers Test an Epilepsy Drug for Osteoarthritis Pain and Cartilage Loss
|

Yale Researchers Test an Epilepsy Drug for Osteoarthritis Pain and Cartilage Loss

A drug used to prevent seizures may one day help people with aching joints. Researchers at Yale tested lacosamide, an epilepsy medication, in early experiments on osteoarthritis. It eased pain and helped protect cartilage at the same time. It does this by acting on a single protein found in both pain nerves and cartilage cells….

New Research Offers Hope for Retinal Disease by Targeting a Protein That Blocks Repair
| |

New Research Offers Hope for Retinal Disease by Targeting a Protein That Blocks Repair

If you lose retinal cells to disease, they stay lost. That rule is why conditions like retinitis pigmentosa and glaucoma are so hard to treat. Zebrafish don’t follow it. They regrow damaged retinal neurons using support cells called Müller glia, and mammals have the same cells. They just don’t use them. A team at KAIST…

New Gene-Editing Treatment Lowered LDL Cholesterol by 52% With Just One Infusion
|

New Gene-Editing Treatment Lowered LDL Cholesterol by 52% With Just One Infusion

What if one treatment could change how your body handles cholesterol for good? Researchers have now tested that idea in people for the first time and followed the results for a full year. The findings are early and come from a small group, but they raise a question that matters to anyone who has ever…

A New Nanoparticle Drug Reversed Memory Loss in Mice With Alzheimer’s After Just Two Shots
|

A New Nanoparticle Drug Reversed Memory Loss in Mice With Alzheimer’s After Just Two Shots

Alzheimer’s disease has resisted decades of research, so a study reporting improved memory and behavior after just two injections deserves a careful look. The results come from mice, not people, and that distinction matters. But the way this treatment works is unusual, and it raises a question researchers have debated for years. Here’s what the…